This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Ironwood Pharmaceuticals, Inc.
Drug Names(s): IW-6118
Description: IW-6118 is a novel small molecule inhibitor of Fatty Acid Amide Hydrolase (FAAH). FAAH is thought to be involved in the regulation of nociception (processing of noxious stimuli), and its substrates include anandamide, an endocannabinoid. IW-6118 decreased inflammation and pain and elevated FAAs in preclinical models.
Additional information available to subscribers only: